All Stories

  1. Curently Trends in HIV Infection
  2. Key Points in HIV Infection Pathology<b></b>
  3. P450 in Liver Pathology Diagnostic
  4. Key Points in HIV Infection
  5. An Approach on HIV Infection
  6. HIV Infection a Social and a Healthcare Problem
  7. OPPORTUNISTIC PATHOGENS IN PATIENTS WITH URINARY TRACT INFECTION
  8. Opportunistic Pathogens in Patients with Urinary Tract Infection
  9. Opportunistic Pathogens in Patients with Urinary Tract Infection
  10. Laboratory Methods in the Screening of Viral C Hepatitis
  11. Disinfectants
  12. Microbial Contamination in Water Systems
  13. Editorial Comment
  14. Assessment of airborne endotoxin in sandstorm dust and indoor environments using a novel passive sampling device in Al Zulfi city, Saudi Arabia – Establishing threshold exposure levels
  15. Virulence profiles of some Pseudomonas aeruginosa clinical isolates and their association with the suppression of Candida growth in polymicrobial infections
  16. Potential Drugs for Treating COVID-19 Infection
  17. Significant help
  18. Study of contact plates recovery from pharmaceutical cleanroom surfaces across three-time ranges
  19. Robust infection prevention
  20. Review of the efficacy of HEPA filtered air to control coronavirus risks in cleanrooms
  21. Antimicrobial Activity of Silver-Treated Bacteria against other Multi-Drug Resistant Pathogens in Their Environment
  22. Assessing Gram-stain error rates within the pharmaceutical microbiology laboratory
  23. COVID-19 and dental practice
  24. Utilities Design and Testing
  25. Use of Hazard Analysis Critical Control Point (HACCP) methodology for biocontamination control: Assessing microbial risks and to determining environmental monitoring locations
  26. A novel mechanism of action of ketoconazole: inhibition of the NorA efflux pump system and biofilm formation in multidrug-resistant Staphylococcus aureus
  27. Particle Counting
  28. Cleanroom Microbiota
  29. Biocontamination Deviation Management
  30. Assessment of Pharmaceutical Water Systems
  31. Bioburden and Endotoxin Control in Pharmaceutical Processing
  32. Biocontamination Control Strategy
  33. Cleanrooms and Environmental Monitoring
  34. Data Handling and Trend Analysis
  35. Designing and Implementing an Environmental Monitoring Program
  36. GMP, Regulations and Standards
  37. Introduction to Biocontamination and Biocontamination Control
  38. Rapid and Alterative Microbiological Methods
  39. Risk Assessment and Investigation for Environmental Monitoring
  40. Selection and Application of Culture Media
  41. Sources of Microbial Contamination and Risk Profiling
  42. Special Types of Environmental Monitoring
  43. The Human Factor and Biocontamination Control
  44. Viable Environmental Monitoring Methods
  45. Disinfectants and Biocides
  46. A review on biocide reduced susceptibility due to plasmid-borne antiseptic-resistant genes-special notes on pharmaceutical environmental isolates
  47. Distribution of biocide resistant genes and biocides susceptibility in multidrug-resistant Klebsiella pneumoniae , Pseudomonas aeruginosa and Acinetobacter baumannii — A first report from the Kingdom of Saudi Arabia
  48. Microbiological Test Data—Assuring Data Integrity
  49. Cleaning and disinfection of dental practice surfaces
  50. A study of airborne fungal allergens in sandstorm dust in Al-Zulfi, Central region of Saudi Arabia
  51. Chapter 7 Clean room design principles
  52. Evaluation of quaternary ammonium compound disinfectants against mycobacteria in dental practices
  53. A review of melanized (black) fungal contamination in pharmaceutical products-incidence, drug recall and control measures
  54. Bacteriophages offer an Antimicrobial Solution
  55. Manufacturing and validation
  56. Microbial identification
  57. Biological indicators
  58. Microbiological data
  59. Bioburden determination
  60. Introduction
  61. Auditing the microbiology laboratory
  62. Introduction to pharmaceutical microbiology
  63. Microbiological challenges to the pharmaceuticals and healthcare
  64. Endotoxin and pyrogen testing
  65. Microbiological culture media
  66. Sterilization and sterility assurance
  67. Microbiology and pharmaceuticals
  68. Cleanrooms and environmental monitoring
  69. Laboratory management and design
  70. Antibiotics and preservatives
  71. GMP and regulations
  72. Rapid microbiological methods
  73. Risk assessment and microbiology
  74. Specified and objectionable microorganisms
  75. Cleaning and disinfection
  76. Microbiology laboratory techniques
  77. Assessment of pharmaceutical water systems
  78. Determination of Minimum inhibitory concentrations of Common Biocides to Multidrug-Resistant Gram-negative bacteria
  79. Pharmaceutical Microbiology
  80. Advances in Rapid Pathogen Detection
  81. Characterizing the Microbiota of a Pharmaceutical Water System-A Metadata Study
  82. Evaluating biocides to kill fungi
  83. Teixobactin: A New Class of Antibiotic
  84. In vitro fungicidal activity of biocides against pharmaceutical environmental fungal isolates
  85. Rapid microbiological methods for cleanroom environments
  86. Interview: Pharmaceutical microbiology
  87. Trichoderma
  88. FUNGI | Classification of the Peronosporomycetes
  89. Laboratory Design
  90. BIOCHEMICAL AND MODERN IDENTIFICATION TECHNIQUES | Enterobacteriaceae, Coliforms, and Escherichia Coli
  91. BIOCHEMICAL AND MODERN IDENTIFICATION TECHNIQUES | Food-Poisoning Microorganisms
  92. Novel Methods to Address Antimicrobial Resistance
  93. The Possible Origins of Tuberculosis in South America
  94. Comparative Evaluation of Traditional Susceptibility Testing for MRSA with the PCR Approach
  95. Comparison of Different Fungal Agar for the Environmental Monitoring of Pharmaceutical-Grade Cleanrooms
  96. Sterility, sterilisation and sterility assurance for pharmaceuticals
  97. Preface
  98. Introduction
  99. Sterility, sterilisation and microorganisms
  100. Pyrogenicity and bacterial endotoxin
  101. Gamma radiation
  102. Electron beam processing
  103. Dry heat sterilisation
  104. Steam sterilisation
  105. Gaseous sterilisation
  106. Hydrogen peroxide vapour sterilisation
  107. Sterilisation by filtration
  108. Other methods of sterilisation
  109. Media simulation trials
  110. Aseptic processing and filling
  111. Depyrogenation and endotoxin
  112. Biological indicators
  113. Regulatory requirements and Good Manufacturing Practices (GMP)
  114. Investigating sterility test failures
  115. The Sterility Test
  116. Cleanrooms, isolators and cleanroom technology
  117. Cleaning and disinfection of sterile processing facilities
  118. Auditing sterilisation processes and facilities
  119. Pharaohs and Mummies: Diseases of Ancient Egypt and Modern Approaches
  120. Global Strategies for Elimination of Leprosy: A Review of Current Progress
  121. Could the ‘Black Death’ Become a Re-Emerging Infectious Disease?
  122. Study of psychrophilic and psychrotolerant micro-organisms isolated in cold rooms used for pharmaceutical processing
  123. Application of Quality Risk Management To Set Viable Environmental Monitoring Frequencies in Biotechnology Processing and Support Areas
  124. In vitro Antifungal Efficacy of Biguanides and Quaternary Ammonium Compounds against Cleanroom Fungal Isolates
  125. Some considerations for the implementation of disposable technology and single-use systems in biopharmaceuticals
  126. Some considerations for the implementation of disposable technology and single-use systems in biopharmaceuticals
  127. A Review of Cleanroom Microflora: Types, Trends, and Patterns